Clin Mol Hepatol.
2025 Apr;31(2):e206-e207. 10.3350/cmh.2025.0164.
Correspondence to editorial on “Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma”
- Affiliations
-
- 1Department of Surgery, Seoul National University Hospital, Seoul, Korea
- 2Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
- 3R&D center, LepiDyne Inc., Seoul, Korea
- 4Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea
- KMID: 2567028
- DOI: http://doi.org/10.3350/cmh.2025.0164
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Screening of patients at high risk of de novo recurrence in HCC: Editorial on “Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma”
- Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma
- Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”
- Correspondence to editorial on “Integrated molecular characterization of sarcomatoid hepatocellular carcinoma”
- Correspondence to editorial on “Evolving trends in epidemiology, etiology, and treatment patterns for hepatocellular carcinoma in South Korea”
